JONATHAN WHITFIELD: Open Payments
NPI 1871622654 · LAKE VIEW TERRACE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,361 in 114 payments from 17 companies in 2025. Trend: 2023 $2,072 · 2024 $3,029 · 2025 $3,361
Food & beverage: $3,361
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $746 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $419 |
| Otsuka America Pharmaceutical, Inc. | 9 | $305 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $254 |
| Supernus Pharmaceuticals, Inc. | 7 | $214 |
| Alkermes, Inc. | 9 | $189 |
| Lundbeck LLC | 6 | $182 |
| Vanda Pharmaceuticals Inc. | 7 | $180 |
| E.R. Squibb & Sons, L.L.C. | 3 | $174 |
| Axsome Therapeutics, Inc. | 2 | $167 |
Products named: VRAYLAR, REXULTI, CAPLYTA, TRINTELLIX, Qelbree, FANAPT, COBENFY, Auvelity.
Industry payments across CA — which companies pay providers there.
